A single week without progress, disrupted sleep, hormonal fluctuations around your cycle, or a period of higher stress can all produce a temporary stall that resolves without any medication change
BPC-157 downregulates NF-kB activity, reducing the local cytokine burden at injury sites
Market Dynamics: From Shortages to Price Pressures After prolonged supply constraints, the FDA officially declared US GLP-1 shortages resolved in April 2025, removing semaglutide and tirzepatide from its shortage list and ending enforcement discretion for compounded versions by May 2025
With currently approved medications like Wegovy and Mounjaro, some people stay on their current dose to maintain results, whilst others can reduce to a lower dose
This swelling may be uncomfortable or itchy
Zepbound (tirzepatide): Side effects may include dehydration, GI issues and low blood sugar, which can lead to fatigue